WP111	Electron transport chain: OXPHOS system in mitochondria	498	4712	521	292	1355	1340	29796	1345	9551	539	517	C00080	4717	506	4702	10975	4696	9016	4729	4700	4513	4715	4726	7386	4695	4539	4509	4725	9377	7385	1353	522	6390	4512	9167	374291	1337	9481WP78	TCA Cycle	4724	1346	1327	C00080	C00080	293	10632	4707	7352	7388	4704	C00080	4709	516	4710	1347	C00080	4541	27109	6389	4536	4706	1349	27089WP4324	Assembly PW Complex 1	291	7381	4540	55967	6341	6392	93974	4713	4694	7384	4711	1329	C00080	4508	4514	4722	1351	4535	4723	6391	518	1339	C00080	6834	4719	4701	4538	10476	4718	4708	4720	1350	513	4716	10063	4697	4698	515	514	509	4731	4705	7351	4537	4728	4714	4519	7350
WP1403	AMP-activated protein kinase signaling	147WP534	Glycolysis	1026	891	148	10645	79602	1978	53632	7249	5562	31	3643	51422	2475	5571	92335	5565	7248	55437	51094	5564	23236	100271849	1375	6517	1374	200186	3172	3953	5209	84254	1938	51719	126129	5567	5563	57521	5568	32WP534	GluconeogenesisWP143	Fatty Acid Oxidation	6517	6517
WP1425	Bone morphogenic protein signaling and regulation	650	659	657	57154	4091	4086	57154	10140	4086	4086	4089	57154	4086	860	57154	4091	658	10766	4086	9241
WP1539	Angiogenesis	5594	405	5290	7010	4086	5335	4318	2247	1387	5155	7010	1432	3091	7077	4313	6714	5155	2321	3791	4313	3091	2263	4318	2247	207
WP1544	MicroRNAs in cardiomyocyte hypertrophy	89780	6774	5595	3976	91807	1827	5579	5579	5595	5879	9759	9734	5170	3479	5599	5594	1147	1022	1499	8517	183	1855	4776	2932	5598	5290	1489	5605	5295	5595	5296	6416	4790	801	801	3480	9020	51564	1154	4776	9759	4776	5594	6093	5170	1025	5592	5293	5330	9641	1432	2263	5595	4638	5894	1906	9734	3551	51564	3572	5609	5291	2932	8503	3084	1950	50804	5599	5532	208	7040	2475	2247	5606	183	5596	5607	4878	5595	5320	5294	6774	7124	9475	1432	5604	4879	10014	387	7474	2626	8893	207	5530	817	10454	5608	10014	4790	2535	4041	4040	8321
WP1591	Heart development	23493	7424	5594	4086	2253	8928	2626	1499	1482	2065	50805	5781	6910	4851	1482	659	57057	8553	4208	150572	650	4208	1482	2296	6910	27302	1482	406937	2303	23462	406904	2626	4776	3670	406935	4772	6909	7422	4851	2626	657	6469	7423	2255	2627	2626	6722	57057	4089	9464	4773	4208	6899	6909	3170	652	650	1482	5308	6722	4775	6910	6910	9421
WP1600	Nicotine metabolism in liver cells	1555	2328	1548	1548	54657	316	1548	54600
WP1603	Nicotine effect on chromaffin cells	1143	8913	775	1136
WP1604	Codeine and morphine metabolism	1565	7364	7364	10599	7364	54658	1244	5243	54658	8714	54659	54576	54600	54575
WP1772	Apoptosis modulation and signaling	407024	332	10018	9131	837	5414	834	3303	55367	54205	7157	5587	4671	331	84883	51651	8737	5783	8797	8743	27429	332	8682	8793	56616	8795	8737	79444	27113	8794	5366	407025
WP4506	Tyrosine metabolism and related disorders	C10438	C02057	C00014	C00544	C00122	C00164	C00931	C00430
WP4518	Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseasesWP5171	Leukotriene	C00302	C00002	C00008	C00008	C00736	C00051	C01879	C00002	C00008	C00002	C00302
WP4519	Cerebral organic acidurias, including diseases	C00806	C00489	C00016WP78	TCA cycle	C00005	C00024	C00956	C01352	C02214	C00004	C00322	C00080WP4228	Saccharopine pathway	C16433	C00010	C16440	C00026	C00003WP4228	Pipecolic acid pathway	C16433	C00080	C00024
WP4523	Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism	C03917	C00535	C00187	C00762	C00410	C02140	C05488	C01227	C00280	C01780	C01953	C00006	C00005WP197	Cholesterol  Biosynthesis	1583	3283	3283	3284WP496	Androgen Synthesis  and Metabolism	1585WP170	Steroid Hormone Signaling
WP4524	Alternative pathway of fetal androgen synthesis	C01953	C00523	C01227	6770	C00006	C00005	C00674	C00280	C00410	C00187	1109	C00003	C00535	C07632	C00004	C00006	C00005	C00003	C00004
WP453	Inflammatory response pathway	3494	3493	942	7133	3913	3458	3507	7059	7448	3558	3566	3560	3932	3912	3561	3565	1281	958	1277	3918	1278	940	959	7132	2335	941	3559	3915	7535	3911	7057	3567	3568
WP4540	Hippo signaling regulation pathways	5562	5563	5564	5565	5571	51422	53632	999	1008	1009	1010	1012	1013	1014	1015	1016	28513	1000	28316	64405	64403	1001	1002	1003	1004	1005	1006	1007	2767	2771	2773	2774	2776	2778	5566	5567	5568	5573	5575	5576	5577	5578	5579	5580	5581	5582	5583	5584	5588	5590	23683	23236	5330	5331	5332	4088WP3963	Mevalonate PathwayWP35	G Protein Signaling	998	4087	2475	26524	6788	9113	55249	4771	6901	4485	7003	55249	6901	8463	7005	7004WP560	TGF-Beta Signaling	2263	3791	3643	2261	3480	3815	2260	1969	1956	1436	2264	2321	2324	4804	4233	5156	5159	7010	2322	4914	4915WP4172	PI3K/AKT Signaling	387	5879WP428	WNT Signaling	51176	83439	6934	6932	1499
WP4541	Hippo-Merlin signaling dysregulation	999	1008	1009	1010	1012	1013	1014	1015	1016	28513	1000	28316	64405	64403	1001	1002	1003	1004	1005	1006	1007	5566	5567	5568	5573	5576	5577	5575	26524	6788	9113	4771	4485	7003	55249	6901	8463	7005	7004	2263	3791	3643	2261	3480	3815	2260	1969	1956	1436	2264	2321	2324	4804	4233	5156	5159	7010	2322	4914	4915	3627	960	57144	60485	5063	56924	94274	1499	595	4609	5747	5332	154796	389421	10298	1490	9686	4893	3265	4659	2305	5058	84962	5062	3845	1495	55249	6901	26524	9113	4771	4771	407054	5499	5500	5501	9730	8451	1642	9978
WP4545	Oxysterols derived from cholesterolWP5064	7-Oxocholesterol and 7Î²-Hydroxycholesterol pathways
WP4549	Fragile X syndrome	C00302	3751	4318	3746	26999	2563	2915	1268	6714	1845	9456	2534	2903	1915	2903	348980	54869WP3676	BDNF-TrkB Signalling	18WP4172	PI3K-Akt-mTOR  Pathway&#xA;	C00302	627	160	23236	2571	C00575	8218	5530	80852	1385	1742	1742	6529	5578	2571	5566	1981	7915	6464	2890	1213	163	1374	5566	84867	2885	1212	10243	23426	1742	2891	351	814	1385	5781	2890	1175	27161	9495	2566	8536	9743	2549	2554	84867	23405	1173	9463	1605	2904	2561	4915	6566	1211	2891	8831	3708	5499	5335	816	50944	1742	58512	5605	2332	4131	23237	8569	6198	4131	5594	3845	23191	84335	23237	5604	815	6654	5526	1979	5894	4763	1977	815	2332	64798	9894	57521	64223	2475	5291	9675	2915	6009	9456	2911	5163	116986	5728	7248	207	7249	51256	6009	3845	58512	50944	2904	2904	2554	2561	2566	10243	6529	18	7915	224	5825	9524	1374	6566	224	5825	9524	5573	5573	2332	2890	2891	2891	2890	2890	2891	6455	1785	1973	6895	1979	4204	2043	2903	1029	3218	5605	5604	5594	8569	673	369	6457	5566	5566	5573	5573	351	2904	160	163	1175	1173	8218	1213	1212	1211	2904	5728	5728	2902	2902	1845	1915	26999	2563	2915	348980	3746	3751	4318	5578	5909	54869	50944	84867	4131	84867	1845
WP4558	Overview of interferons-mediated signaling pathway	3716	3716	7297	3717	6772	6772	6772	6773	6772	6773	3716	5295	5290	5578	10379	10379	3455	3454	3459	3460	3439	3444	3458	3716	7297	6772	6773	163702	3588	282618	282616	282617	101180976	3442	3443	3441	3440	3445	3446	3447	3448	3449	3451	3452	3456	338376	3467	56832	6772	6773	10379	6772	6773	6772	6772	6772	6772
WP4595	Urea cycle and associated pathways	C00327	C16433	C00024WP4225	Pyrimidine  metabolism&#xA;and diseases	C01602	C00086	C16435	C00302	C00122	C01342WP106	Aspartate  metabolism	C00022	C01432	C00303	C01401	C00711	C00288	C16433	C02385	C01602	C00327	C00302WP4225	Pyrimidine metabolism and diseases	C00295	C00299	C00105	C00106	C01342	C00533WP4571	Urea Cycle	C00711	C00302
WP3297	EV release from cardiac cells and their functional effects	7124	2066	406935	10365	6387	6004
WP3300	Dual hijack model of Vif in HIV infection	8065	861	6921	865	7314	6923	9978	865	865
WP3407	FTO obesity variant mechanism	84159	79191	10265	7350	63976	10891	6899	79068WP368	Fatty Acid Oxidation	79068
WP3408	Evolocumab mechanism to reduce LDL cholesterol	255738	3949	255738	3949	255738	3949	3949	3949
WP3413	NOTCH1 regulation of endothelial cell calcification	4851	55553	249	6303	813	2261	3672	2702	28514	10683	54567	182	3714
WP3529	Zinc homeostasis	4520	7779	91252	55334	57181	221074	64116	283375	55630	29985	29986	27173	4489	7779	4490	4493	4494	4495	4496	4499	4501	4502	4504	4500	84560	7922	201266	55334	10463	7782	64116	55532	7781	7782	7780	23516	64924	7780	148867	7782	55676	25800	169026
WP4927	COVID-19, thrombosis and anticoagulation	C01591	C07625	2243WP1818	Formation of fibrin clot  (clotting cascade)WP272	Blood clotting  cascadeWP4580	Blood clotting  and drug effectsWP558	Complement and  coagulation cascadesWP4462	Platelet-mediated interactions with  vascular and circulating cells	2244	2266	2266	2243	2244	C01591
WP4966	Fluoroacetic acid toxicity	C00311	C06108	C00158	224	223	C15488WP78	Cytric acid cycle (Krebs cycle)	217	1431
WP4971	Phosphoinositides metabolism	C00002	C00001	C00009	C01245	C00008	C00080
WP500	Glycogen synthesis and degradation	5837	5516	5257	2998	5526	5261	5527	801	5255	5522	5834	7360	2997	2931	5523	2992	5518	808	5529	5515	7360	8908	5528	5521	178	5525	805	28227	5256	5520WP534	Glycolysis	2932	5260	5519	2632	5236	5524	5836
WP5030	Ethylmalonic encephalopathyWP78	OXPHOS  pathway	C00736	C05359	C00283	C00022	C00007
WP5037	Riboflavin and CoQ disordersWP241	One carbon metabolismWP5274	Mevalonate pathwayWP4225	Pyrimidine metabolism and related disorders	C01352WP111	OXPHOS	C00061	C00020	C00061	C00016	C00016	C00016	C00016	C00013
WP4228	Vitamin B6-dependent and responsive disorders	55163	C00250	C00408	C00018	C00018	C00250	C00449	C00534	C00534	C00314	C00314	55163
WP5049	Glycolysis in senescenceWP3404	Oxidative stress	C01432	5925WP3308	Oncogene induced senescence	C00022	C00303WP78	TCA cycle	2539	3939WP3391	SASPWP3308	Oncogene induced senescence	C00716WP4562	NF-kB signalingWP534	Glycolysis	5230	7157	2597	5315
WP2516	ATM signaling pathway	993WP707	DNA Repair	891	1647	1385	7161	995WP254	ApoptosisWP254	ApoptosisWP1859	G2/M Transition	983	472	5883	5888	983	898WP254	Cell DeathWP615	SenescenceWP45	S Phase Arrest	7157WP707	DNA RepairWP1859	G2/M Checkpoint ArrestWP45	S Phase Progression	1386WP707	DNA Repair	7158WP45	S Phase Progression	472	472	472WP1775	Cell Cycle Checkpoint ActivationWP707	DNA DAMAGEWP438	Recombination
WP2525	Trans-sulfuration, one-carbon metabolism and related pathways	26227	29968	5723	7298	1719	200895	4522	10797	441024	1719	1719	4522	10797	441024	4548	635	875	2937	2729	2730	2937WP5176	Bile acid biosynthesis	55224	2880	6647	51380	56994	200895	5130	4144	2936	C00588	9468	55500	10390	6649	4143	2882	1491	2937	55349	1788	23743	4524	1759	5337	6648	257202	1120	2571	1036	2572	27232	635	6470	5833	1757	2879	2877	2876	4548	2730	2878	10768	102724560	29958	570	6472	1119	7298	2729	10400	C02356	586	64902	2729	2937	587	2730	275	27430	1789	29947	191	23382
WP254	Apoptosis	407024	407021	5366	842	4193	578	7187	3659	4790	355	329	56616	207	3002	27242	572	4792	834	8737	3660	4793	4049	837	3664	836	5551	7132	3480	5970	1147	581	317	7133	843	330	637	8718	5602	7185	3551	3663	1676	54205	4793	27113	3661	835	8739	7161	9169	840	4609	7124	3481	8738	8517	666	7186	8837	599	5295	8717	332	3479	8795	3725	665	1677	8717	596	7132	3665	5970	598	3662	4794	7157	6416	8737	1029	841	331	572	4792	356	8743	4794	3070	4790	8772	4170	839	10018	4214	8626	407025
WP26	S1P receptor signal transduction	8877	56848	427	6610	1901	9294	1903	53637	23236	5330	5331	5595	5594	5597	5596	5598	6300	2770	2771	2773	207	208	10000	5287	29127
WP268	Notch signaling	9794	5664	83464	1857	196403	10683	3714	3065	182	113878WP382	MAPK signaling pathway	8650	3955	9612	7124	171558	1856	1387	151636	51107	4854	1840	6868	4853	28514	3516	1855	54567	9253	5986	23385	4855	4851	3762	1487	4242	388585	3280	23220	5663	55534	1488	3066
WP272	Blood clotting cascade	3818	C00290	2266	5328	2244	3816	7450	5345	5055	5054WP4136	Fibrin Complement  Receptor 3 Signaling	2243
WP2846	PCSK9-mediated LDL receptor degradation	3949	255738	255738	3949	3949	3949	255738	3949	255738	3949	255738	3949	255738	3949	3949	3949
WP4191	Caloric restriction and aging	10135	C00002	23411	C00020	C00003
WP4195	Phosphatidylcholine catabolism	C00550	C00114	C13038	C00002	C00588WP3933	Kennedy pathway	C00008
WP4220	Neurotransmitter disorders	C01598	C05584	C00547	C03758	C00082	C00780WP4156	Biosynthesis and regeneration  of tetrahydrobiopterin and &#xA;catabolism of phenylalanine	6571	C05582	C00078	C01017	C05587	4128	C00355	4128	4128	C03758	C00780	6571	C00547	6571	C00018WP4156	Biosynthesis and regeneration  of tetrahydrobiopterin and &#xA;catabolism of phenylalanine
WP4223	Ras signaling	100137049	2902	C00035	C00076	6237	2903	2904	C00076	3363	1436	1956	1969	2260	2261	2263	2264	2321	2322	2324	3480	3643	3791	3815	4233	4804	4914	4915	5156	5159	7010	801	805	808	810	91860	51806	163688	5923	5924	C00575	5566	5567	5568	10681	2782	2783	2784	2785	2786	2787	2788	2790	2791	2792	2793	51764	54331	55970	59345	94235	5335	5336	10125	10235	25780	115727	7535	27040	C00076	2885	6464	25759	53358	399694	2549	9846	5781	6654	6655	22800	22808	3265	3845	4893	C00044	6237	22800	22808	3265	3845	4893	4763	100271927	10156	22821	5921	5922	64926	8437	8831	9462	11186	83593	6789	6789	7074	5879	5880	5881	10298	106821730	5058	5062	5063	56924	57144	387	207	208	10000	1147	3551	8517	4790	5970	572	598	4303	356	4301	8036	5894	8844	283455	5604	5605	5594	5595	8315	2113	2114	2002	123745	255189	26279	283748	30814	391013	50487	51365	5319	5320	5321	5322	64600	81579	8398	8399	84647	8605	8681	9771	5906	5908	5900	23179	5863	5898	5899	5599	5601	5602	55770	84630	5966	5337	5338	10928	5879	5880	5881	998	51196	5578	5579	5582	9610	10928	382	5879	5868	5869	5878	25	27	C00076	5290	5291	5293	5295	5296	8503
WP4224	Purine metabolism and related disorders	C00119	C00002	C00655	C01733WP4292	Methionine metabolism  and disorders	C00020	C01762	C00559	C00294	C00035	C00361	C00131	C00002	C00206	C00212	C00360	C00081	C00262	C00387	C00019	C00001	C00385	C00008	C00044	C00286	C02380	C00366	C00147	C00242	C00362	C00144	C00130	C00119	C03838	C03373	C00008	C00002	C00008	C00002	C00008	C00002	C00008	C00002	C00008	C00001
WP4225	Pyrimidine metabolism and related diseasesWP4571	Urea cycle	C00303	C00295	C00075	C00214	C16433	C00112	C02642	C00299	C01602	C00429	C00475	C00906	C00105	C00327	C01346	C00365	C00106	C00055	C00063	C00119	C00015WP5037	Riboflavin and CoQ Disorders	C00299	C00178	C00288	C00526	C00364	C00295	C00303	C00288	C00302	C01342
WP5190	Creatine pathway	6535	C02385	C00791	2593	C00300	C00581	C00008	C00008	C00300	2628	C00002	C00302	C16435	C00002	C01602	C00021	C00791	4942	C01602WP4595	Urea cycle
WP5193	Cholesterol synthesis disorders	6713	1717	C00235	6307WP197	Cholesterol biosynthesis pathway	3930	2222	C01802	C01189	10682	3157	4597	10654	1718	C05437	2224	3422	C01724	6309	3284	1595	C01107	C00187	3156	4047	C00356	4598	2224
WP5195	Disorders in ketolysisWP197	Cholesterol synthesis	C00091	C00042	C00356	C00164WP5193	Cholesterol synthesis disorders
WP524	G13 signaling pathway	6242	5585	1073	85415	387	5216	9138	23191	10672	10788	8826	5293	397	5291	57630	3984	4608	5879	10188	5063	5305	5602	801	8976	5296	5500	7454	4216	4632	11113	398	6093	1729	5290	998	6198	9475	1072
WP5241	Mitochondrial beta-oxidation
WP5275	Ether lipid biosynthesisWP357	Fatty acid biosynthesis	C00010	C00010
WP528	Acetylcholine synthesis	5130	5161	43	5160	10400	1119	1103
WP399	Wnt signaling pathway and pluripotency	8325	324	1487	4316	1856	1499	89780	3725	11211	4800	5584	2103	7480	5328	7482	1387	5515	5516	6932	6934	5578	51176	6657	10009	29127	5602	2535	51384	7472	7484	7474	5518	83439	5467	2033	5588	26190	51701	333926	7471	5579	5587	27022	4609	7475	1855	5048WP183	26S Proteasome Degradation	6416	7481	7157	595	7473	5521	5601	28227	5460	7476	1488	5519	5529	5590	4040	8322	1857	5582	8061	8313	8326	387	8323	85407	8324	85409	10023	8312	79923	5527	2932	54361	5520	1454	5522	7976	1500	80326	3949	6885	7481	5581	7855	896	5523	5583	960	7477	81029	8321	5580	5524	4041	894WP254	Apoptosis	120892	1499	1499
WP400	p38 MAPK signaling pathway	9261	2885	7186	8550	3315	6464	5608	4293	5879	7046	4209	1386	6772	1385	4217	8569	6885	8737	9252	1432	2002	4149	1432	3265	998	3150WP254	Apoptosis	5321	6416	1649	5923	9261	7042	1616	4214	4609	8717
WP4030	SCFA and skeletal muscle substrate metabolismWP534	Glycolysis	5467	C00163WP500	Glycogen synthesisWP1403	AMPK activation	C00246	C00033	5697WP143	FA oxidationWP481	Insulin actionWP3965	Lipolysis	C00163	C00033
WP405	Eukaryotic transcription initiation	5430	55703	1022	2958	3611	2963	2959	5440	51728	6883	2966	6908	5431	5434	5432	2071	171568	2968	6884	64425	2967	6877	5436	84172	661	2068	5438	2965	5439	6878	25885	2960	902	55718	5437	51082	6880	4331	2961	5435	6879
WP408	Oxidative stress response	4257	6667	6648	4790	4501	4784	27035	5602	4780	2729	3162	1432	10587	2353	847	1543	3726	2953	6649	2876	50507	7498	7296	2878	54578	4128	2936	25828	1728	6647	1536	50508	79400
WP410	Exercise-induced circadian regulation	4618	687	9709	10946	11335	51582	5685	51663	7341	8341	5813	1408	5187	8864	1407	5507	1051	5516	8031	2120	26059	3108	3312	3301	7352	2947	7360	7122	5281	10381	2674	23118	6612	2950	10787	9218	8987	9802	3422	10140	11030	50486	406	9975	9575	694	1982	9444	5187	8864	1407	1408	1408	1407	8864	5187
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	C06135	C06133	C04730	C00195	100874511	100874498	100874499	100874500	100874512	C02686	C00716	C00195	C04884	C04911	C04927	C06134	C06141	C06140	C06136
WP4150	Wnt signaling in kidney disease	100532724	387	1499	27130	4041	4040	7471	80326	7480	7476	51384	7475	7474	7482	7481	54361	89780	81029	7484	7472	7473	7477	8321	8325	8322	2535	8324	8326	7855	8323	7976	8321	8325	8322	2535	8324	8326	7855	8323	7976	1856	1857	1855	5601	5602	5599	1856	1857	1855
WP4153	Degradation pathway of sphingolipids, including diseases	950	5660	C06126	C03272	2720	2717	2717	C06135	C04730	C00195	C04884	C04911	C06136	2760	2760	2720	2720	4864	10577	3988
WP4156	Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine	56521	C00019	C00547	C00780	C00044	C00007WP4220	Neurotransmitters (dopamine/serotonin)	C00007	56521	C00019	C01598
WP4157	GABA metabolism (aka GHB)	C00042	C02714	4129	C00884WP143	fatty acid beta-oxidation spiral	C00134WP78	TCA cycle	C00160	C00018	C00303	C00106	C00018
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	C00164	C00024	C00004WP5241	Mitochondrial  beta-oxidation of &#10;fatty acidsWP197	cholesterol  synthesis	C00332	C00024	C00332	C00024	C00332	C00164	C00080	C00080	C00080	C00003
WP465	Tryptophan metabolism	C05637	217	3620	169355	2639	217	C08313	438	169355	1543	C00463	1738	4128	4128	1644	847WP534	Glycolysis/Gluconeogenesis	6772WP4210	Nicotinate and  nicotinamide metabolism	1644	1644	4128	C00246	38	3620	125061	15	64577	316	56267	130013	C02693	8564	C00955	8942	11185	C08481	C06213WP3925	Phenylalanine, Tyrosine and  Tryptophan metabolism	23498	26	4128	3620	8942	11185	1892	6999	121278	C00483	C00695	438	169355	125061	8942	169355	3620	169355	6772	6772
WP4657	22q11.2 copy number variation syndrome	642643	100996435	25786	23752	400892	728418	7157	4099WP3310	Mitochondrial translation	5905	5347WP3561	tRNA modification in the  nucleus and cytosolWP1793	Cell junction organization	5071	596	100652736	9978	7514WP4443	p75 NTR receptor-mediated signalling	5430	440799WP558	Complement and Coagulation Cascades	10298	9076	9611	6097	8131	1365	8452	C02385	1104	266697	101928891WP254	Apoptosis	6720	3842WP4083	Reelin signalling pathwayWP4900	Purinergic signaling	57142	8841	9681	406	645348	C16440	648980	5649	5901	6721WP2706	Activation of gene expression by SREBF (SREBP)	23176	113691WP411	mRNA ProcessingWP1793	Tight junction	10892	84222WP35	G Protein Signaling pathways	C00002	10641	1013	55752WP481	Insulin Signalling	7450WP2436	Dopamine metabolismWP272	Blood Clotting CascadeWP1591	Heart development	2812	2811WP1870	Neurotransmitter clearance	1813	2814	2815	3053	2746	388849	421	5894	51586	8659	84861	8216	7353	80764	6545	85359	C00158	400891	4942	23617	5894	8479	C16435	9464	8036	65078	8318	6517WP2735	RAS/MAPK signal transduction	128989	9993	150197WP497	Urea cycle	2928	7122	54584	C01602	150209	10587	5902	C00303	79680	7625	5500	9127	8220	C00302	23468WP78	TCA cycle	27037	5297	25842	64976	373856	C07937	8218	7290	5077	60385	2255	6576	1399	91179	C00376	284361	C05582	C00777	6722	29102	3170	5625	2253	56603	1312	8646	2296	1399	6469	C00547	1592	C03758	5308	29801	2253	2263	54487	6899	340665	2303	C00777	2260	1482	8854	C05587	9342	2263	2260	998	54487	3280	3280	2637268	Notch signalling	2812	5894	C00158WP78	TCA cycleWP1823	GP1b-IX-V activation signalling	59	70	C03758	3170	2296	2303	6899	26220	1956	60385	100133163	6097	5902	3837	5430	84861	5347	9681	9681	9127	C02385	C16440
WP466	DNA replication	5001	5981	5425	5984	C00075	6117	5111	23594	4174	8318	8317	51053	7316	57804	4175	81620	5985	29935	10926	6118	5424	4171	1017	6119	5557	4999	5983	55388	10714	23649	5000	4176	4173	5427	7311	990	23595	5426	4998	C00460	5982	4172	5422
WP4688	Serine metabolism	C01005	C00305	C00003	C02737	C00018	C00037	C00022	C00031WP534	glycolysis	C00080	C00118	C03232	C00004	C00302	C00001	C00364	C00365	C00101WP534	glycolysis
WP4720	Eicosanoid metabolism via cytochrome P450 monooxygenases pathway	2053	1579	284541	284541	66002	8529
WP474	Endochondral ossification	249	6696	2261	4322	176	657	3549	2260	3481	654	3479	54407	7040	C02465	51719	4208	1280	11096	864	5741	8817	801	85477	860	2247	55553	5727	5167	5566	11127	5727	445341	860	50515	1515	7042	207	2688	2737	3157	7422	4318	871	655	1028	6662	7067	860	6772	9510	7067	2690	5328	4256	6777	1300	9507	7040	3480	8100	4921	579	1473	2487	5327	9759	5744	5745	6660	7078
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	7067	5745	6300	6615	1432	5744	8817	2254	C07639	5600	6772	9474	3549	650	5894	5603	2261	4882	1267	5745	652	6662	5933	1026	5933	5515	5604	5605	5594	5595
WP4803	Ciliopathies	2736	112	124401	51473	114327	1258	1259	95681	203286	5310	5311	6608	30849	4952	4750	167691	9657	56623	23432	201163	8239	10806	51715	5314	168507	9731	2737	284086	51684	374654	1406	27031	27130	132884	2121	7546	7840	122481	63929	221322	55624	30849	84662	63917	83479	23090	7287	8481	27152	201163	10733	10464	4952	29922	219844	26005	9731	84131	4751	55857	84140	79848	153241	95681	84984	1063	23568	146845	91754	25814	57545	8481	51057	23093	10210	51134	7275	202018	6102	9786	9364	25886	282809	22897	146057	132320	80184	220136	79140	9851	585	65062	79583	51259	51524	84314	91147	79867	200728	79600	55812	10806	23322	9657	57096	94137	26123	6101	261734	80184	4867	54903	57545	167691	80776	27077	54806	89765	2622	347736	345643	83544	161582	54919	64446	10309	1768	374407	55036	54768	388389	8701	51364	92749	6674	83861	339829	85478	54919	345895	221421	123872	27019	55172	352909	9094	26160	403	583	79809	92002	57728	11020	79738	80184	54903	166379	4117	10806	84100	55212	92482	112752	54585	55764	8195	57539	585	26146	55081	582	6102	129880	28981	123016	57560	27241	51057	22954	23059	5147	51098	200894	9742	51626	79659	51626	79659	79809	57728	112752	55764	57539	9742	583	79738	80184	54903	166379	10806	84100	55212	92482	54585	8195	585	582	129880	123016	27241	51057	22954	26160	11020	26146	55081	28981	57560	23059	51098	9094	403	6102	5147	200894	92002	4117
WP4876	Activation of NLRP3 inflammasome by SARS-CoV-2	7187	114548	5970	4790	3553	834
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	3538	3497	3122	920	926	3123	3543	10394	925	1401	3929	3126	3503	3576	3501WP4846	SARS-CoV-2 ORFs	55922	914	5725029	3127	3500	3569	919	3932	916	7535	2534	28755
WP179	Cell cycle	8317	1022	5347	1029	10459	5111	1017	2932	9700	4171	7157	994	8900	890	5925	3065	8379	5934	5933	8318	472	7040	902	9232	11200	983	9088WP382	MAPK signaling  pathway	991	4089	898	995WP254	Apoptosis	25	5925	9134	545	2810	3066	10744	51343	6500	7529	1017	1647	1021	990	2033	1028	6502	894	9184	7531	5925	7533	85417	10971	7534	4172	7465	4173	4174	1019	4175	5591	4176	10393	4998	1026	4999	890	23595	4088	5000	9126	5001	4193	23594WP183	Ubiquitin-mediated  proteolysis	4087	699	7042	896	7043	9133	5933	7532	1874	891	1875	983	7027	1111	7029	1029	4609	8900	7709	1030	1031	1032	595	1027	8454	9978	1869	1870	7027	1871	7029	1874	1875	7027	7029	4616	10912	993	7272	27127	8243	10274	10735	5885	494551	25847	29882	29945	51433	51434	51529	64682	8697	8881	996	991	10393	25847	29882	29945	51433	51434	51529	64682	8697	8881	996	6500	6502	8454	9978	4998	4999	23595	5000	5001	23594	4171	4172	4173	4174	4175	4176
WP197	Cholesterol biosynthesis pathway	50814	C01054	2224	3157	6307	6713	3422	4597	1595	3156	1717	10654WP143	Fatty Acid Beta Oxidation	6309	2222	4047	4598	2224
WP1995	Effects of nitric oxide	4846	4151	4842	4512	4843	7498
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	6720	23411	3156	51586	51548	2475	10062	5465	10891	2194	6319	6721	3157	3949	19	5562
WP2253	Pilocytic astrocytomaWP422	Regular MAPK  Cascade pathway	6654	2885	5894	5781	4763	673
WP2338	miRNA biogenesis	5901	57510	29102	23405	54487	23405
WP2371	Parkinson's disease pathway	2058WP254	Apoptosis Pathway	1644	6531	7345	5071	6622	7054	120892	65018	11315	27429	54205	2861	5413	9627	7314	7317	7318	7332	9246	118424	7326	7327	51465	6311	23208	898	9134	6622	9627	6300	5600	1432	5603WP111	Oxidative PhosphorylationWP254	Apoptosis Pathway	839	842	835	54205	840	836	317WP382	MAPK SignalingWP399	WNT Signaling	406921	406979	406980	406981	406916	574038	406994	406902	100187716	100616127	442906	406951	100302181	407029	574506	574506	407042	407015	407016	407041	407042	407015	407016	407041	406971	406971	407017	407017	407017
WP2406	Cardiac progenitor differentiation	3630	5460	79923	6657	79727	389421	132625	7070	6656	5080	64321	3170	4684	290	83881	4920	89780	652	3624	2932	2247	55897	145873	3791	3815	7852	5156	4851	3670	1482	2626	6910	57057	4208	1432	649	9241	4838	7040WP399	WNT	22943	4624	7139	7137	91807	140885	4208	7139	70	4633	6331	50805	3481	3479	89780	3084
WP241	One-carbon metabolism	4143	635	2745	10588	1719	10797	4522	25902	2346	123263	1786	4522WP4225	Thymidylate Synthesis	4548	4524	25902	10841	1789WP438	Non-homologous end joining	23382	10840	275	4552	27430	10841	6470	275WP531	MIsmatch repair	7298	4522	2618	6472	25902	1788	C01817	471	10797	191	6948	2618	1719	1719
WP2447	Amyotrophic lateral sclerosis (ALS)	5530	1432WP707	p53 Signaling PathwayWP254	Apoptosis	4842	5532	5868WP2267	synaptic transmission,  glutamatergicWP183	Proteasome	5608	4744	57679	7124	4741	847	5605	5879	5533	9973WP382	MAPK Signaling Pathway	2876	1616	4217	4747	5630	7157	317	836	842	79139	834	637	6647	596	598	581	572	100506742	7124	7132	2890	6647	4217WP254	Apoptosis	6647	6647
WP3624	Lung fibrosis	255520WP3929	Chemokine signalingWP129	Matrix metalloproteinasesWP2798	Collagen productonWP474	Chondrocyte differentiationWP2666	Stress fibre assemblyWP2848	Differentiation PathwayWP2884	NRF2 signalingWP560	TGF beta signalingWP530	Cytokines and inflammatory&#10;responseWP254	Apoptosis	51750	2920	6696	91039	2246	6351	4092	7012	729238	5073WP382	MAPK signaling	6347	5265	6498	7124	653509	3569WP408	Oxidative Stress	1906	2006	1440	26585WP288	Inflammasome activation	1832	7015	4204	3576	796	7039	3596	3553	1232	6352	5154WP3396	NADPH oxidase	6356	23250	2247WP453	Inflammation	1215	3567WP558	Coagulation disturbances	1950	7076	3593	655	5155	5806	4780	4318	2252	727897	1051	57105	3162WP400	p38 MAPK	4313	3082	6440	729230	3565	1437	5328	10144	6348	4502	3479	7040WP288	Inflammasome activationWP75	Toll-like receptor signaling
WP382	MAPK signaling pathway	7189	4208	6722	6197	5606	2005	5906	1398	3552	5155	10000	51295	9175	115727	6885	5601	2885	8569	1843	3925	2002	1956	5532	5533	11184	4772	409	4137	10125	5908	929	8517	627	1616	5602	7124	369	6789	1432	3551	408	120892	836	2316	5566	9261	7132	9020	3315	51776	2768	7040	4214	10746	4149	11221	5924	9448	5159	10454	4216	1647WP428	Wnt signaling pathway	5607	994	3554	5880	5580	5536	5604	5879	5778	7850	23118	7046	5594	5801	84867	283748	673	4914	1386	6416	C00338	2353	5582	4609	6655	7042	2002	5598	1846WP254	Apoptosis	3312	6300	9479	5494	3553	2005	7186	5603	57551	5608	1850	208	8550	5922	1849	5535	2260	7043	5530	1950	1649	9064	1326	4803	1399	9344	5595	5599	3164WP179	Cell cycle	5578	468	4909	5154	468	4915	356	5159	5495	2263	998	2261	8649	2264	3725	6654	3727	6237	3265	9252	7786	7157	22800	4790	55970	8605	4763	10235	207	25780	115727	5921	5923	3310	4908	9693	5567	3303	5568	6788	1845	8491	1147	7048	4791	5871	5970	5609	5971	5534	1852	51701	1844	80824	355	2872	5321	4775	4217	4296	51347	1848	5605	5600	8986	7867	5881	23542	23162	2317	2318	3304	3305	3306	22808	4893	3845	5894	255189	100137049	123745	10369	27091	27092	55799	59283	59284	59285	773	774	775	776	777	778	779	781	782	783	784	785	786	8911	8912	8913	9254	93589	2249	2246	2247	2248	2249	2250	2251	2252	2253	2254	2255	2256	2257	2258	2259	26281	26291	27006	8074	8817	8822	8823	9965	5062	5058
WP3871	Valproic acid pathway	116285	3032	54659	1962	1555	3065	3028	3030	1548	1559	36	3712	18	36	1548	1555	1559	1548
WP3890	Nanomaterial-induced inflammasome activation	7099
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3398	3662	860	6774	3394	1437	7173	3394	1435	1435	1435	6774	6774	1435	3394	55509	1435	3394	55509	3662	1435	1437
WP3933	Kennedy pathway from sphingolipids	10390	C00588	10400	1120	C00055	8879	9791	1119	9468	5833	55500	5130	55224	56994	81490
WP3972	PDGFR-beta pathway	5290	5159	5335	5578	3716	5579	6778	3717	6774	6772	6776	2885	3265	6654	6464	5921	6777	5894	2002	6722	2353	3725
WP5166	Glyoxylate metabolismWP4361	Gluconeogenesis	C11102	C00022	C00048	C00209	C00048	C00209	C00022	C00041	C00037	C00065	C00041	C11102	C11102	C00016	C00048	C01157	C01157	C00209	C00160	C00160	C00209	C00160	C00209
WP5169	Hemesynthesis defects and porphyrias	C02191	C01051	C05768	C01079	C00032	5498	C00931	C01024	3145	C05766	C00091	211	210	212	7390	7389	1371	2235	C03263
WP5173	Disorders of galactose metabolism 	2997WP500	Glycogen synthesis  and degradation	2632	5836	8908	2992	2998	231	2582	5236	C00369	2592	6523	C00052	C00029	C01582	2584	6514	C01582	C01582
WP5175	Disorders in ketone body synthesisWP534	GlycolysisWP4521	Glycosylation	C00332WP78	Tricarboxylic acid cycle	C00024	C00164	C00207	C16439	C00003WP368	Mitochondrial long chain  fatty acid beta-oxidation	C00080	C00004	C00024	C00080WP4686	Leucine, isoleucine and  valine metabolismWP4190	Mevalonate biosynthesis
WP5176	Disorders of bile acid synthesis and biliary transport	10599	28234	8309	6342	C05460	C01921	C05122	3295	C15613	6342	C02737	8647	C01558	1244	10998	C00187	1581	C17339	C01921	5244	9420	80270	C05122	C05337	C00695	C15610	6718	C05466	C05465	80270	1593	5205	1593	6718	1593	6718	C02737	C01558	C00187	1593	1593	3295	3295	3295	1593	1593	C01921	C05122
WP5178	Disorders of fructose metabolism	6514	C00794	216	5236	132158	5211	C02154	C00089	C00031	2821	6652	2203	6523	C00369WP534	Glycolosis and  gluconeogenesis	C02336	7167	C00022	3795	229	C02336	C00794	C00031	3098
WP5186	Vitamin K metabolism and activation of dependent proteins	C00828	C05377	C02059WP4313	Ferroptosis	C00006	C00302	C00302	C00302	C00302	C00302	C00302	C00302	C02059
WP5188	Retinol metabolism	C05917WP4342	Vitamins A and D - action mechanisms (Homo Sapiens)WP716	Vitamin A and carotenoid metabolism  (Homo sapiens)
WP2853	Endoderm differentiation	6772	79923	5744	57669	3915	63978	4088	23168	7040	4838	2186	64321	2626	6928	5083	123169	5015	1601	6422	9573	4851	3198	2131	54623	3720	26986	8320	5460	3175	3169	7080	1499	6932	83881	9646	1847	4089	7478	1994	9350	3170	22943	351	57690	657	30009	4087	55832	655	6657	9241	1846	79577	51176	3227	3087	2627	3720	3975	724023	442918	494324	406933	2908	1844	2146	8928	6478	23682	324	83595	5606	7473
WP2854	Gene regulatory network modelling somitogenesis 	2253	6911	134701	145873	2043	84667	3280	4851	3955	4851	28514	89780	4851	28514	89780	2253	2253
WP2857	Mesodermal commitment pathway	8554	51701	63035	23181	27245	23373	2005	5090	79776	23007	115825	5566	8320	9241	9573	5916	79668	8463	4838	115825	79977	84667	4086	27244	6001	4088	2296	688	3717	7546	1466	8450	4089	28514	10413	2131	23576	27244	10155	57198	595	5080	10973	58499	79035	4211	652	442895	3064	7003	659	11190	23499	5087	84159	6911	8030	26610	10973	92	29970	3172	8728	23007	203228	6926	79668	2627	85363	4091	89780	2296	11190	83439	84295	58499	2260	9113	6899	55704	7403	8312	3251	10124	57669	54799	5087	655	93	79923	3169	6925	6615	3170	27324	5460	1466	83881	6169	154091	10124	8928	5308	8646	2303	7473	31	9314	29072	657	9760	3624	55809	595	404220	6657	343930	51176	5573	8091	6722	57045	3170	9421	5515	57198	3251	90	4087	22943	2132	5915	10637	8553	55809	10451	6925	268	2625	64321	7044	79923	8322	7855	8325	2253	8313	4780	6657	51366	11166	708	7547	131405	1789	11169	3720	1488	22823	85416	121536	54892	23528	79977	80312
WP2858	Ectoderm differentiation	25987	4089	5236	345557	1952	8495	8322	8325	4920	407042	460	9079	6347	4982	54828	10634	5292	57621	157807	11177	8345	51222	57476	56899	2300	2627	7343	9687	1756	56913	54207	51701	4204	4609	79776	57621	494323	6238	54521	3801	5787	79731	398	5452	5420	5010	54898	6498	114815	51422	23133	10253	51592	114822	7855	5362	6781	152789	4609	7593	4061	7903	5269	398	4772	57621	2720	5297	1896	170302	56963	7226	406949	8675	84809	6785	27324	10486	8835	10257	29970	5467	3170	6622	5080	5077	55843	2737	6469	1499	7471	8473	7026	91653	9924	1487	440193	83933	25806	23229	1496	3728	54903	27352	6386	1896	2263	3853	3148	1501	7704	1004	8848	1006	4926	3975	6929	51043	151613	51762	4771	51701	22871	60401	5783	54806	79776	2534	5150	50937	6016	57154	6907	10013	652	657	83439	8820	4990	79658	9935	7022	6657	7020	57621	2274	6498	54880
WP2868	TCA cycle nutrient use and invasiveness of ovarian cancer	6774	5595	3716	5594	1956WP78	TCA Cycle	6774	1956	3716	6774
WP2884	NRF2 pathway	6513	23491	4199	5052	2938	66035	2877	3082	54657	2258	645	2729	4259	23657	4780	2940	114134	1244	7295	10257	6649	56606	2878	131	2042	2936	3326	2952	155184	144195	140809	54577	5226	873	218	1548	5467	874	7040	2539	54578	7296	7042	8714	54600	2950	221223	22949	221357	54658	9588	3320	2678	2941	1728	3337	1066	283848	7039	2953	7364	81031	154091	2939	2730	10057	23764	3084	6518	4258	5265	8878	1958	8824	6517	6514	54659	11182	29988	2512	1969	3162	4097	1839	3303	9817	2495	7048	6515	5155	177	114112	1579	6256	2949	2944	2946	2947	2948	6524	6523	6527	125206	200010	8884	115584	159963	6526	60482	160728	6528	6530	6529	6532	6538	6536	6533	6540	11254	6531	6534	6535	9152	28968	55117	348932	54716	388662	340024	29986	27173	55630	57181	55334	25800	201266	221074	29985	7922	64116	283375	91252	23516	4780	9817	4780	4780
WP289	Myometrial relaxation and contraction pathways	10267	3489	51764	8786	5590	111	6261	489	468	2985	5577	5582	108	5581	3488	2868	2784	2785	5570	2353	2869	5021	85366	55970	5997	54331	9628	3725	109	2788	5567	1388	59	10266	11318	796	114	107	409	466	4842	2869	26575	5583	6262	64407	7529	3569	2870	27297	59350	1264	7533	818	6000	4635	5996	5579	85366	1902	10268	817	5588	4846	800	9446	1392	5578	7534	2868	1265	5576	409	2783	2791	5021	3487	6263	6001	8525	8490	488	3485	8601	2776	10681	7531	5020	5573	8787	2810	113	22809	5336	3553	2787	133	6004	3710	5587	71	94235	122042	59345	5575	10287	60	10699	2553	5580	6667	2551	112	2980	3708	816	1394	6013	5144	2870	2114	467	196883	5333	5999	10636	6546	2981	408	2697	408	7532	784	57007	3484	11142	5142	2792	5569	10971	10488	70	3486	5335	2778	23764	5566	808	1386	2786	805	115	801	58	2782	4633	5998	3709	5331	815	4790	1385	2982
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2048	1051	4094	5290	2729	5599	7965	4780	5578	4780	9817	3162	23657	1728	2939	2730	9817	C10484	1051	4780	9817	4780
WP3286	Copper homeostasis	22823	261729	351	26872	6667	79689	8754	102	6868	55240	2308	9973	1317	150684	1318	4489	4490	4493	4494	4495	4496	4498	4500	4501	4502	4504	84560	5621	540	54739	475	4193	7157	4137	5290	4520	389160	538	836	595	3725	6649	23621	1353	10063	331	2309	324	6647	5728	2932	4891	6341	9997	351	10063	540	538	55240	79689	1317	C00070	475
WP3287	Overview of nanoparticle effectsWP408	Oxidative stressWP98	Prostaglandin pathwayWP1539	AngiogenesisWP707	DNA damage responseWP231	TNF-a SignalingWP51	CytoskeletonWP364	Il-6 signaling	3162WP2509	Autophagic cell deathWP179	Cell cycleWP2783	Immune system up or down regulationWP2513	NecrosisWP306	Cell adhesionWP558	Blood coagulationWP453	InflammationWP2513	NecroptosisWP2848	DifferentiationWP2507	Apoptosis	7124
WP4236	Krebs cycle disorders	C01401WP111	mtDNA synthesis	5106	C00122	2271	C00022	C01432	C00091	C00008	C00002	C00044	C00158	C00042	C00035	C00022	C01401
WP4238	Flavan-3-ol metabolic pathway	C00230	C00010	C00010	C00010	C00010	C00010	C00230	C05616
WP428	Wnt signaling	1857	387	5879	5328	5579	817	10023	2932	1460	324	89780	5534	5535	7976	5601	51176	1454	595	8325	83439	7476	6934	7481	7471	5578	3725	4041	11211	8324	5533	81029	5530	1499	7472	1452	7482	6424	5582	816	1856	7475	896	7474	4919	8321	4040	83999	51384	8323	818	6259	54361	815	7473	1457	8312	7480	7855	7477	1855	57680	5532	80326	122011	283106	8061WP306	Focal Adhesion	5602WP183	26S Proteasome  Degradation	4609	1459	894	8326	6885	6932	51384	2535	4920	1499	1499	22943	27123	27121	50964	5176	23401	1499	6422	6423	6424	6425	147111	9350	11197	64840	81029	7474	7976	8325	11211	8324	6424	8321	8323	7855	8326	2535	23236	5330	5331	5332	4772	4773	4775	4776	4772	4773	4775	4776	7976	8325	11211	8324	6424	8321	8323	7855	8326	2535	2239	81839	57216	7481	1857	1856	1855	27130	144165	166336	85407	85409	23002	23500	9475	5599WP382	MAPK Signaling Pathway	80319	59343	51701	56998	64321	1487	1488
WP4288	MTHFR deficiency	C00114WP4304	Myelin  components	C00019	79813	4524	C00157	836	C01026	C05330	C05207	C00588	C00076	C00195	C01733	C00307	1788	C00576	C00719	C00143	1789WP254	Apoptosis	C00550	842WP3941	Oxidative Damage	438	C00350WP4259	Folate metabolism  and related disorders	10919	1312	C00719	C00114	C00019	C00019	C00019	C05330	C05330	C00076	C05330	C00076	1786
WP430	Statin inhibition of cholesterol production	19	64241	335	337	19	344	407039	345	341	116519	1581	949	5360	64240	336	3931	3949	338	8694	4023	693120	6713	3990	6646	348WP4190	Mevalonate arm in more detail	4035	2222	84532	1071	3156	4547	64714
WP4352	Ciliary landscape	6103	80344	8655	55812	51138	55764	3065	7021	83741	10238	7022	3066	92482	9342	64708	2717	140735	51098	4236	27183	4704	57414	4171	4172	25904	54585	339488	54903	10413	10432	1857	10421	23019	27241	324	254394	9859	875	9318	7322	4927	246175	1488	149371	5476	79598	26286	112752	7020	11020	5866	84515	11018	6629	167691	9883	4174	85456	55746	9343	4173	56912	396	7465	10920	5862	55245	1499	25804	4698	55036	10980	55388	51552	4176	1387	23011	2077	10083	22981	80173	815	23549	4790	28981	55081	1039	4436	90410	8533	9742	23301	64072	55207	4175	23059	2181	10726	8526	9255	79874	2664	8636	1892	123016	5393	50813	65125	5925	51314	8100	57560	26160	64792	150737	92104	79989	51668	23059	26146	23233	54536	23265	10640	55770	11336	55763	60412	55770	11336	55763	23233	54536	23265	10640	60412	5899	582	583	129880	585	55212	5048	83657	83658	10982	6993	6990	261726	6990	1778	6993	5048	1781	51143	25861	7431	79699	2720	4747	4741	63929	79018	25852	10048	64777	57610	10296	4289	54994	3934	80232	51646	80258	10424	7328	64795	27429	1655	116225	4218	203286	124401	140609	284086	4637	9882	80184	10788	801	10128	9657	128239	8826	1345	2040	140465	5879	9669	23404	54512	23016	5719	30845	25980	80005	80199	5714	57136	10051	10555	5713	10939	8732	5706	5718	9217	27152	5704
WP4357	NRF2-ARE regulation	2932	2048	1051	4094	5290	2729	5599	7965	4780	5578	3162	23657	1728	2939	2730	1051	4780	9817	4780	2534	6714	7525	4780	3643	192111	4780	9817	8452	9978	9817	9817	8452	9978	2534	6714	7525
WP4462	Platelet-mediated interactions with vascular and circulating cells	6401	3553	958	958	7412	3383	5196	C00780	6352	7040	959	3553	6347	7042	7043
WP4482	Vitamin D in inflammatory diseases	4790	1147	3551	8517	5970	4792	3569	7124	6256	4089	5530	5534	5606	4088	4772	1843	1432	5608	4214	7421	7421	9282	2908	7421	4088	4772	5970	4790	4792	6256
WP534	Glycolysis and gluconeogenesis	7167	5214	2203	226	92483WP134	Pentose Phosphate Pathway	5315	230	6514	2805	2597	1738	5091	5213	2806	5230	4190	5313	6518	5160	4191	3939	3098	6513	5224	1737	5211	2027	2023	3948	3101	3945WP325	Triglyceride synthesis	25874	51660	2026WP500	Glycogen metabolism	2538	3099	5105	5232	6517	8789	6515	2645	5223	5315WP78	TCA Cycle	229	2821
WP545	Complement activation	716	713	715	712	714	731	10747	717	718	735	732	729	721	1604	720	730	727	717	721	718	717	721	727	713	714	712	715	716	733	5648	718	629	718	718	629	1675	718	5199	718	629	5199	727
WP550	Biogenic amine synthesis	2572	1644	7166	3067	1621	1644	7054	5409	43	1312	5053	1103	15	2571	4128	438	4128	1644
WP581	EPO receptor signaling	2057	3717	6714	2057	6772	6464	2885	5604	5595	5594	5605	5163	207	5294	2056	2056	8651	6777	1154	6776	6774	6774	6772	5788	10076	2885	5894	6654	8660	3717	3667	5921	5894	6654	5921
WP585	Interferon type I signaling pathways	9846	1398	867	2889	6198	C00044	5777	3455	3716	79109	1399	1977	8554	1978	57521	27250	6774	3667	8651	9021	2534	3454	6772	6773	1975	5293	5879	5781	5606	6775	7535	C00035	1399	5788	10379	10401	8986	6775	7297	2475	64223	1973	3932	5966	1385	6776	3276	5608	6773	2475	5906	8660	9252	5295	7409	6194	4214	10399	1432	3455	6772	6772	3455	6774	5879	5296	6772	6774	6774	6772	6773
WP690	Polyol pathway	229	231WP534	Glycolysis	6652WP534	Glycolysis
WP698	Glucuronidation	7360	5238	5239	55276	3098	7358	5236	7367	54657	54576	79799	54578	7366	7363	7365	54575	54579	10941	54658	54600	54490	574537	7364	10720	54659	54577
WP78	TCA cycle (aka Krebs or citric acid cycle)	3420WP143	Degradation of Fatty Acids	6389WP1847	Metabolism of amino acids	8801	50	8802	1743	3421	6391	50	3418	6392WP111	Electron Transport Chain	6390	1431	3419WP497	Urea cycle	1738WP357	Fatty Acid Synthesis	4967WP534	Glucose metabolism	2271	4191	8802
WP98	Prostaglandin synthesis and regulation	C00762	1583	308	1910	5734	6281	6277	5737	5740	5732	5731	3248	5743	5617	244	5321	307	7356	5730	1906	306	3290WP35	Gq signaling pathway	301	5729	5739	3291	5742	309	1909	6916	5733	302	10257	27306	4286	9536	5468	10891	133522	6662	8644	873	1645	1646	1645	6915	5738
